U.S. private equity firm Bain Capital has bought Mitsubishi Tanabe Pharma in a deal worth 510 billion yen ($3.4 billion), ...

The Japanese chemical company has agreed to sell its pharmaceutical business to Bain Capital for more than $3 billion, in a ...

Mitsubishi UFJ Financial Group's dividend yield and buyback program boost value. Learn why MUFG stock is a solid investment ...

The investment firm is acquiring Mitsubishi Tanabe Pharma in a deal valued at $3.3 billion. Elsewhere, Bausch + Lomb hasn’t ...

With EV sales growth slowing and threats by President Trump to impose tariffs, pause infrastructure buildout and end federal ...

Mitsubishi Corp has recorded an impairment charge of Y52.2bn ($342.4m) on its offshore wind projects in Japan.

Mitsubishi Motors is facing a tough financial year, with the company slashing its net profit forecast by a staggering 76%.

Mitsubishi Motors Corp. (MMC) is planning to invest P7 billion in the Philippines in the next five years, Malacañang ...

Following rumblings of a private equity bidding war late last year, Bain Capital has emer | Bain Capital is laying out 510 ...

Mitsubishi Electric Corporation (TOKYO: 6503) announced today that the international nonprofit CDP has once again given ...

Mitsubishi Corp. took a 52.2 billion yen ($342.4 million) impairment charge on its domestic offshore wind projects in the ...

Bain Capital, a leading global private investment firm, today announced it has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation ("Tanabe Pharma", "MTPC" or "the Company") ...